These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 30364187

  • 21. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J, Adamsson J, Harandi AM.
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [Abstract] [Full Text] [Related]

  • 22. Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.
    Tritel M, Stoddard AM, Flynn BJ, Darrah PA, Wu CY, Wille U, Shah JA, Huang Y, Xu L, Betts MR, Nabel GJ, Seder RA.
    J Immunol; 2003 Sep 01; 171(5):2538-47. PubMed ID: 12928404
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Volckmar J, Knop L, Stegemann-Koniszewski S, Schulze K, Ebensen T, Guzmán CA, Bruder D.
    Vaccine; 2019 Aug 14; 37(35):4963-4974. PubMed ID: 31320219
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host.
    Belyakov IM, Isakov D, Zhu Q, Dzutsev A, Klinman D, Berzofsky JA.
    J Immunol; 2006 Nov 01; 177(9):6336-43. PubMed ID: 17056564
    [Abstract] [Full Text] [Related]

  • 31. Species-dependent role of type I IFNs and IL-12 in the CTL response induced by humanized CpG complexed with β-glucan.
    Kobiyama K, Temizoz B, Kanuma T, Ozasa K, Momota M, Yamamoto T, Aoshi T, Kuroda E, Ishii KJ.
    Eur J Immunol; 2016 May 01; 46(5):1142-51. PubMed ID: 26786557
    [Abstract] [Full Text] [Related]

  • 32. Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis.
    Tiwari RK, Chandrakar P, Gupta CL, Sayyed U, Shekh R, Bajpai P.
    Int Immunopharmacol; 2021 Jan 01; 90():107181. PubMed ID: 33249044
    [Abstract] [Full Text] [Related]

  • 33. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
    McCluskie MJ, Weeratna RD, Davis HL.
    Mol Med; 2000 Oct 01; 6(10):867-77. PubMed ID: 11126201
    [Abstract] [Full Text] [Related]

  • 34. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice.
    Inoue J, Yotsumoto S, Sakamoto T, Tsuchiya S, Aramaki Y.
    Pharm Res; 2005 Oct 01; 22(10):1627-33. PubMed ID: 16180119
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Polylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses.
    Kaiser-Schulz G, Heit A, Quintanilla-Martinez L, Hammerschmidt F, Hess S, Jennen L, Rezaei H, Wagner H, Schätzl HM.
    J Immunol; 2007 Sep 01; 179(5):2797-807. PubMed ID: 17709493
    [Abstract] [Full Text] [Related]

  • 38. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets.
    Linghua Z, Xingshan T, Fengzhen Z.
    Mol Immunol; 2007 Feb 01; 44(6):1141-9. PubMed ID: 16911828
    [Abstract] [Full Text] [Related]

  • 39. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q, Tan MT, Keegan BP, Barry MA, Heffernan MJ.
    Biomaterials; 2014 Sep 01; 35(29):8385-93. PubMed ID: 24986256
    [Abstract] [Full Text] [Related]

  • 40. Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
    Kar UK, Jiang J, Champion CI, Salehi S, Srivastava M, Sharma S, Rabizadeh S, Niazi K, Kickhoefer V, Rome LH, Kelly KA.
    PLoS One; 2012 Sep 01; 7(7):e38553. PubMed ID: 22808011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.